All intelligent investing is value investing – acquiring more than you are paying for.

Investor Portal

What we offer

Reasons to invest

  • Addressing areas of high unmet medical need:
    • Immuno-OncologyPrimary focus on advanced gastrointestinal tumors without surgical option
    • Vaccination: For protection against newly emerging or re-emerging infectious diseases


Targeting largest drug market segments
Immuno-Oncology market drivers
  • Cancer remains a global burden with increasing number of cancer-related deaths
  • Focus on innovative treatments that reduce reappearance of cancer
  • Clinical success of immunotherapeutics induced paradigm shift in cancer therapy
Vaccine market drivers
  • Increasing global supply causes escalating demand for vaccines
  • Start of governmental vaccination programs to eradicate endemic diseases
  • Launch of novel and innovative vaccine technologies
Global Immuno-Oncology market expectation
Global Vaccine market expectation
bn USD by 2026
0 %
bn USD by 2026
0 %

Favourable Risk Profile


If you are interested in investing in CanVirex AG or would like to receive more information on our products and technology, please get in touch with us.